SCHEMBL379219

SCHEMBL379219

C#CCC(CC#C)(C(=O)O)C(=O)O

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17818683 0.97 CYP1A2 (0.31) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL16419664 0.85 ALDH1A1 (0.39) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL23856676 0.84
SCHEMBL16418483 0.78 CYP2C19 (0.37) CYP2D6CYP2C19ALDH1A1
SCHEMBL25362363 0.75
SCHEMBL1027710 0.74
SCHEMBL3047206 0.72
Silver SCHEMBL17818682 0.72 BBOX1 (0.32)
SCHEMBL29134071 0.72
SCHEMBL9747384 0.72 TSHR (0.36) CYP1A2CYP2D6MAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025102171-A1 COMBUSTIBLE CONTAINERS MANUFACTURED USING REACTIVE INJECTION MOLDING OF AZIDO POLYMERS GENERAL DYNAMICS ORDNANCE AND TACTICAL SYSTEMS - CANADA, INC. (CA) 2025-05-22 WO disclosed
US-20240190880-A1 SMALL MOLECULE DEGRADERS OF ESTROGEN RECEPTOR WITH CEREBLON LIGANDS REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-06-13 US disclosed
US-20240150360-A1 Small Molecule Degraders of CBP/p300 Proteins THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-05-09 US disclosed
US-20230357249-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND UNIV MICHIGAN REGENTS (US) 2023-11-09 US disclosed
EP-4208500-A1 POLYMERS CONTAINING REPEATING UNITS WITH SEVERAL METAL OR ORGANIC SULPHONATE UNITS, METHODS FOR PREPARING SAME AND USES THEREOF CDP-Innovation (FR) 2023-07-12 EP disclosed
US-20220388978-A1 CEREBLON E3 LIGASE INHIBITORS REGENTS OF THE UNIVERSITY OF MICHIGAN 2022-12-08 US disclosed
EP-4021580-A1 CEREBLON E3 LIGASE INHIBITORS The Regents Of The University Of Michigan (US) 2022-07-06 EP disclosed
WO-2022049236-A1 POLYMERS CONTAINING REPEATING UNITS WITH SEVERAL METAL OR ORGANIC SULPHONATE UNITS, METHODS FOR PREPARING SAME AND USES THEREOF CDP INNOVATION (FR) 2022-03-10 WO disclosed
WO-2021231927-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2021-11-18 WO disclosed
WO-2021055756-A1 SPIROCYCLIC ANDROGEN RECEPTOR PROTEIN DEGRADERS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2021-03-25 WO disclosed
WO-2010088286-A1 SYNTHETIC CONJUGATES AND USES THEREOF SMARTCELLS, INC. (US) 2010-08-05 WO disclosed
CN-100448841-C Process for preparing 2-cyclohexenone compounds UNIV ZHEJIANG (CN) 2009-01-07 CN disclosed
CN-101104587-A 2-cyclohexenone compounds UNIV ZHEJIANG (CN) 2008-01-16 CN disclosed
CN-100358857-C 2-cyclohexenone compounds and preparation method thereof UNIV ZHEJIANG (CN) 2008-01-02 CN disclosed
CN-1951903-A Process for preparing 2-cyclohexenone compounds UNIV ZHEJIANG (CN) 2007-04-25 CN disclosed
CN-1827577-A 2-cyclohexenone compounds and preparation method thereof UNIV ZHEJIANG (CN) 2006-09-06 CN disclosed
EP-0807101-B1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS UPJOHN CO (US) 2001-06-13 EP disclosed
US-5936000-A 2-aminoindans as selective dopamine D3 ligands PHARMACIA & UPJOHN COMPANY (US) 1999-08-10 US disclosed
EP-0807101-A1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS PHARMACIA & UPJOHN COMPANY (US) 1997-11-19 EP disclosed
WO-1996023760-A1 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS PHARMACIA & UPJOHN COMPANY (US) 1996-08-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357249-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND AR, GPER1, CRBN CYP1A2 169/4885CYP2D6 568/4885MAPT 3146/4885
US-20240150360-A1 Small Molecule Degraders of CBP/p300 Proteins EP300, CREBBP, NCOR1 CYP1A2 3688/4885CYP2D6 3390/4885MAPT 1498/4885
US-20240190880-A1 SMALL MOLECULE DEGRADERS OF ESTROGEN RECEPTOR WITH CEREBLON LIGANDS ESR1, CRBN, ESR2 CYP1A2 661/4885CYP2D6 672/4885MAPT 3618/4885
US-20220388978-A1 CEREBLON E3 LIGASE INHIBITORS CRBN, CUL3, UBE3A CYP1A2 3810/4885CYP2D6 4059/4885MAPT 2147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.